GlassScriptPhysician profile
Lathan William Mccall
NPI 1639599657
$7,063.82
in general payments reported to CMS, 2019-2025
30 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $367 · 2021: $240 · 2022: $620 · 2023: $2,429 · 2024: $1,905 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,231 · Travel and Lodging: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,231.05 |
| Travel and Lodging | $1,055.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,571.55 | 2023 | Intracept |
| Abbott Laboratories | $1,444.41 | 2021-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $667.84 | 2020-2025 | Artisan, Wavewriter Alpha Prime 16, Intracept |
| Becton, Dickinson and Company | $550.00 | 2019 | |
| Medtronic, INC. | $535.09 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $324.34 | 2024 | Senza |
| Abbvie INC. | $297.27 | 2023-2025 | |
| Spr Therapeutics, INC | $287.56 | 2020-2025 | Sprint Pns System |
| Valinor Pharma, LLC | $190.88 | 2023-2025 | Movantik |
| Collegium Pharmaceutical, INC. | $165.02 | 2022-2023 | Belbuca, Xtampza |
| Si-Bone, INC. | $149.59 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.71 | 2022-2025 | Relistor |
| Globus Medical, INC. | $136.42 | 2025 | Senza |
| Virtus Pharmaceuticals LLC | $76.47 | 2024-2025 | Levorphanol Tartrate |
| Penumbra, INC. | $67.02 | 2024-2025 | Penumbra System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $60.02 | 2024 | Painteq |
| Route 92 Medical, INC. | $54.44 | 2023-2024 | 8f Base Camp Sheath System |
| Vertex Pharmaceuticals Incorporated | $54.05 | 2024-2025 | |
| Vertos Medical, INC. | $53.40 | 2023-2024 | Mild Device Kit |
| Tricoast Surgical Solutions LLC | $42.74 | 2024 | |
| Azurity Pharmaceuticals, INC. | $33.18 | 2024 | Horizant |
| Averitas Pharma INC. | $23.66 | 2023 | Qutenza |
| Stryker Corporation | $22.53 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $19.43 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $17.59 | 2022 | |
| Almatica Pharma LLC | $16.18 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.20 | 2021 | |
| Saluda Medical Americas, INC. | $14.35 | 2023 | Evoke Scs |
| Biodelivery Sciences International, INC. | $14.26 | 2021 | |
| Tonix Medicines, INC. | $13.62 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lathan Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.